Table 2 Summary of HCMV-tetramer in HLA-A24 individual groups
Age(yr.) (n = 519) | 0–4 (n = 202) | 5–9 (n = 106) | 10–14 (n = 108) | 15–19 (n = 58) | 20–29 (n = 45) |
|---|---|---|---|---|---|
Number of tet(+) | 39(19%) | 32(30%) | 23(21%) | 24(41%) | 15(33%) |
CD8(%) | 20.0 ± 5.7 | 18.6 ± 5.1 | 19.5 ± 6.9 | 22.3 ± 8.3 | 24.8 ± 6.4 |
Tet(%) | 0.05 ± 0.07 | 0.02 ± 0.03 | 0.02 ± 0.01 | 0.04 ± 0.06 | 0.03 ± 0.03 |
Tet/CD8(%) | 0.21 ± 0.31 | 0.12 ± 0.10 | 0.15 ± 0.24 | 0.14 ± 0.16 | 0.12 ± 0.10 |